| Integrating real-world evidence in the regulatory decision-making process: a systematic analysis of experiences in the US, EU, and China using a logic model M Li, S Chen, Y Lai, Z Liang, J Wang, J Shi, H Lin, D Yao, H Hu, COL Ung Frontiers in Medicine 8, 669509, 2021 | 36 | 2021 |
| Applying regulatory science in traditional chinese medicines for improving public safety and facilitating innovation in China: a scoping review and regulatory implications Z Liang, Y Lai, M Li, J Shi, CI Lei, H Hu, COL Ung Chinese Medicine 16, 1-16, 2021 | 23 | 2021 |
| An evaluation of randomized controlled trials on nutraceuticals containing traditional Chinese medicines for diabetes management: a systematic review J Shi, H Hu, J Harnett, X Zheng, Z Liang, YT Wang, COL Ung Chinese Medicine 14, 1-20, 2019 | 21 | 2019 |
| Efficacy and safety of traditional Chinese medicines for non-alcoholic fatty liver disease: a systematic literature review of randomized controlled trials Z Liang, X Chen, J Shi, H Hu, Y Xue, COL Ung Chinese medicine 16, 1-38, 2021 | 20 | 2021 |
| Application of implementation science framework to develop and adopt regulatory science in different national regulatory authorities J Shi, X Chen, H Hu, COL Ung Frontiers in Public Health 11, 1172557, 2023 | 3 | 2023 |
| Is there a role for traditional and complementary medicines in managing chronic fatigue? a systematic review of randomized controlled trials Y Li, J Yang, CI Chau, J Shi, X Chen, H Hu, COL Ung Frontiers in pharmacology 14, 1266803, 2023 | 1 | 2023 |
| Systematic analysis of randomised controlled trials of Chinese herb medicine for non-alcoholic steatohepatitis (NASH): implications for future drug development and trial design X Chen, J Shi, Y Lai, Y Xue, COL Ung, H Hu Chinese Medicine 18 (1), 58, 2023 | 1 | 2023 |
| Benchmarking Drug Regulatory Systems for Capacity Building: An Integrative Review of Tools, Practice, and Recommendations J Shi, X Chen, H Hu, COL Ung International Journal of Health Policy and Management, 2023 | 1 | 2023 |
| The evolving regulatory system of advanced therapy medicinal products in China: a documentary analysis using the WHO Global Benchmarking Tool standards J Shi, X Chen, H Hu, COL Ung Cytotherapy, 2024 | | 2024 |
| Efficacy and safety of traditional Chinese medicine for cancer-related fatigue: a systematic literature review of randomized controlled trials J Yang, Y Li, CI Chau, J Shi, X Chen, H Hu, COL Ung Chinese Medicine 18 (1), 142, 2023 | | 2023 |
| Integrating real-world evidence in the regulatory decision-making process: a systematic documentary analysis of experiences in the US, EU and China using a logic model M Li, S Chen, Y Lai, Z Liang, J Wang, J Shi, H Lin, D Yao, H Hu, COL Ung FRONTIERS MEDIA SAAVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE CH-1015, SWITZERLAND, 2021 | | 2021 |
| PMD6 How to Promote the Application of Regulatory Science in Combination Products H Lin, J Wang, Y Lai, Z Liang, J Shi, M Li, LC Ieong, H Hu, COL Ung Value in Health Regional Issues 22, S59, 2020 | | 2020 |
| PMD7 Analysis of Medical Device Recall Reports in China from a Regulatory Science Perspective: Implications for Post-Marketing Surveillance J Wang, H Lin, Y Lai, Z Liang, J Shi, M Li, LC Ieong, H Hu, COL Ung Value in Health Regional Issues 22, S59, 2020 | | 2020 |
| PNS33 Developing and Adopting Regulatory Science: Experiences of Drug Regulatory Authorities in China, United States, European Union, and JAPAN J Shi, YF LAI, Z Liang, J Wang, H Lin, M Li, LC Ieong, H Hu, COL Ung Value in Health Regional Issues 22, S87, 2020 | | 2020 |
| PNS25 Applying Regulatory Science to Traditional Medicines for Improving Public Safety and Facilitating Innovation: Experiences in China Z Liang, Y Lai, J Shi, H Lin, J Wang, M Li, LC Ieong, H Hu, COL Ung Value in Health Regional Issues 22, S85, 2020 | | 2020 |
| 发展和应用监管科学: 中国, 美国, 欧盟和日本的药品监管机构的经验 时君楠， 梁钻姬， 赖云锋， 胡豪， 吴霭琳 中国食品药品监管, 38-55, 2020 | | 2020 |
